Dental care is a high-growth segment owing to the ample supply of high quality clinical talent, potential to standardise clinical procedures and the relatively low cost of setting up a dental practice. Added to this is the rising incidence of dental illnesses, irrespective of age or geography.
Helion today announced a Series A investment of INR 27 crores in Denty’s, a multi-speciality dental care chain. Helion is the first and only institutional investor in the company. Started in the year 2009, Denty’s now counts over 100,000 satisfied patients across all their 10 clinics in 5 cities in Andhra Pradesh and Tamil Nadu. Sanjeev Agarwal, Senior Managing Director, Helion and Ritesh Banglani, Director, Helion will join the board of the company.
Denty’s integrates technology that enables evidence-based dentistry for value conscious patients across tier 1 and tier 2 towns in India. Denty’s is a paperless dental centre; having implementing digitized diagnostic imagery integrated with an electronic health records system since the inception stage.
Denty’s launched its first clinic in 2009 in Vijayawada, Andhra Pradesh and currently operates 10 clinics across 5 cities in Andhra Pradesh and Tamil Nadu. Denty’s will utilise the funds to expand its presence across the country, and bring up the number of clinics to 150, in five years.
Denty’s founders Dr. Sekhar Chennupati and Dr. Rajesh Nandipati bring a combined experience in dentistry and healthcare management. Dr. Sekhar Chennupati, is an oral and maxillo-facial surgeon with an experience of over a decade and a half. Dr. Rajesh Nandipati is a medical doctor with a master’s degree in Healthcare Management from the US.
” Customers across 5 different cities enthusiastically recommend the clinics to their friends and families, giving us confidence in the team’s ability to create a high-quality dental practice nationwide”, said Sanjeev Aggarwal, Senior Managing Director, Helion
Dr. Sekhar Chennupati, Cofounder, Managing Director, Denty’s added, “The Series A funding from Helion will fuel the replication of our proven, scalable model across the country, enabling us to reach out to a larger population.”
Helion has previously invested in EyeQ, a chain of specialty eye hospitals and LifeCell, India’s largest stem cell bank.
